Rachel Humphrey - Net Worth and Insider Trading
Rachel Humphrey Net Worth
The estimated net worth of Rachel Humphrey is at least $35,374 dollars as of 2024-09-20. Rachel Humphrey is the Chief Medical Officer of CytomX Therapeutics Inc and owns about 30,234 shares of CytomX Therapeutics Inc (CTMX) stock worth over $35,374. Details can be seen in Rachel Humphrey's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rachel Humphrey has not made any transactions after 2018-03-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rachel Humphrey
Rachel Humphrey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rachel Humphrey owns 5 companies in total, including Black Diamond Therapeutics Inc (BDTX) , CytomX Therapeutics Inc (CTMX) , and Mirati Therapeutics Inc (MRTX) among others .
Click here to see the complete history of Rachel Humphrey’s form 4 insider trades.
Insider Ownership Summary of Rachel Humphrey
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BDTX | Black Diamond Therapeutics Inc | 2020-09-08 | Chief Medical Officer |
| CTMX | CytomX Therapeutics Inc | 2018-03-02 | Chief Medical Officer |
| MRTX | Mirati Therapeutics Inc | 2013-07-12 | EVP and Chief Medical Officer |
 | | 2021-10-21 | director |
| | 2022-08-11 | director |
Rachel Humphrey Latest Holdings Summary
Rachel Humphrey currently owns a total of 1 stock. Rachel Humphrey owns 30,234 shares of CytomX Therapeutics Inc (CTMX) as of March 2, 2018, with a value of $35,374.
Latest Holdings of Rachel Humphrey
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2018-03-02 | 30,234 | 1.17 | 35,374 |
Holding Weightings of Rachel Humphrey
Rachel Humphrey Form 4 Trading Tracker
According to the SEC Form 4 filings, Rachel Humphrey has made a total of 0 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years. The most-recent trade in CytomX Therapeutics Inc is the sale of 16,160 shares on March 2, 2018, which brought Rachel Humphrey around $484,800.
Insider Trading History of Rachel Humphrey
- 1
Rachel Humphrey Trading Performance
Rachel Humphrey Ownership Network
Rachel Humphrey Owned Company Details
What does Black Diamond Therapeutics Inc do?
Who are the key executives at Black Diamond Therapeutics Inc?
Rachel Humphrey is the Chief Medical Officer of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , 10 percent owner Biotech Growth N V , and director & 10 percent owner Ali Behbahani .
Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary
Over the past 18 months, Rachel Humphrey made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 221,600 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 221,600 shares. During the past 18 months, 246,600 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,075,850 shares were bought by its insiders, resulting in a net purchase of 4,829,250 shares.
Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Black Diamond Therapeutics Inc Insider Transactions
Rachel Humphrey Mailing Address
Above is the net worth, insider trading, and ownership report for Rachel Humphrey. You might contact Rachel Humphrey via mailing address: C/o Mirati Therapeutics Inc., 4660 La Jolla Village Drive, Suite 500, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
